Matches in Wikidata for { <http://www.wikidata.org/entity/Q73293587> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q73293587 description "article scientifique publié en 2000" @default.
- Q73293587 description "artículu científicu espublizáu en payares de 2000" @default.
- Q73293587 description "im November 2000 veröffentlichter wissenschaftlicher Artikel" @default.
- Q73293587 description "scientific article published on 01 November 2000" @default.
- Q73293587 description "wetenschappelijk artikel" @default.
- Q73293587 description "наукова стаття, опублікована в листопаді 2000" @default.
- Q73293587 name "Rofecoxib, a new cyclooxygenase 2 inhibitor, shows sustained efficacy, comparable with other nonsteroidal anti-inflammatory drugs: a 6-week and a 1-year trial in patients with osteoarthritis. Osteoarthritis Studies Group" @default.
- Q73293587 name "Rofecoxib, a new cyclooxygenase 2 inhibitor, shows sustained efficacy, comparable with other nonsteroidal anti-inflammatory drugs: a 6-week and a 1-year trial in patients with osteoarthritis. Osteoarthritis Studies Group" @default.
- Q73293587 type Item @default.
- Q73293587 label "Rofecoxib, a new cyclooxygenase 2 inhibitor, shows sustained efficacy, comparable with other nonsteroidal anti-inflammatory drugs: a 6-week and a 1-year trial in patients with osteoarthritis. Osteoarthritis Studies Group" @default.
- Q73293587 label "Rofecoxib, a new cyclooxygenase 2 inhibitor, shows sustained efficacy, comparable with other nonsteroidal anti-inflammatory drugs: a 6-week and a 1-year trial in patients with osteoarthritis. Osteoarthritis Studies Group" @default.
- Q73293587 prefLabel "Rofecoxib, a new cyclooxygenase 2 inhibitor, shows sustained efficacy, comparable with other nonsteroidal anti-inflammatory drugs: a 6-week and a 1-year trial in patients with osteoarthritis. Osteoarthritis Studies Group" @default.
- Q73293587 prefLabel "Rofecoxib, a new cyclooxygenase 2 inhibitor, shows sustained efficacy, comparable with other nonsteroidal anti-inflammatory drugs: a 6-week and a 1-year trial in patients with osteoarthritis. Osteoarthritis Studies Group" @default.
- Q73293587 P1433 Q73293587-F5003D0E-15A1-47ED-BD6E-A37C784365A3 @default.
- Q73293587 P1476 Q73293587-6F68A354-10DA-484D-946B-6E4B7A2EABAD @default.
- Q73293587 P2093 Q73293587-2762F1E8-0F10-4608-9FE7-9B39C840C19C @default.
- Q73293587 P2093 Q73293587-676C9CFC-28D2-471E-9C52-3922D47FA3F6 @default.
- Q73293587 P2093 Q73293587-718DB3BC-C2BD-494D-9458-1947E611003F @default.
- Q73293587 P2093 Q73293587-84F7F0A2-D3EE-4EC7-9FFD-1F021E079095 @default.
- Q73293587 P2093 Q73293587-A931EC80-7152-4747-B926-6EE53100BBE3 @default.
- Q73293587 P2093 Q73293587-E3E77887-DC14-48F5-8FED-9D8E33BE65C6 @default.
- Q73293587 P2093 Q73293587-F898BFCE-DFA3-435A-AE4D-063B8CBEACF8 @default.
- Q73293587 P304 Q73293587-966DEF87-333E-49C6-B8CD-54C09289DC90 @default.
- Q73293587 P31 Q73293587-3F5965C9-0041-4476-B327-5E262D6A31D6 @default.
- Q73293587 P356 Q73293587-5951DDB6-7594-4ED1-BBE2-CD55C302E67A @default.
- Q73293587 P433 Q73293587-A267CB69-43B1-47F3-A43D-CDE81E5C510D @default.
- Q73293587 P478 Q73293587-7714CA7D-45B3-4352-AF82-C3B34FE2FB99 @default.
- Q73293587 P50 Q73293587-43A8B40C-5127-447F-B190-0B482144F7E1 @default.
- Q73293587 P577 Q73293587-4A44F34B-D09F-414C-893C-35048220F93A @default.
- Q73293587 P698 Q73293587-3D3981F8-80EB-43CB-95D7-2A73C50AD190 @default.
- Q73293587 P921 Q73293587-59786ADF-31D4-48F1-AD54-3151D46B1C66 @default.
- Q73293587 P356 ARCHFAMI.9.10.1124 @default.
- Q73293587 P698 11115219 @default.
- Q73293587 P1433 Q27710162 @default.
- Q73293587 P1476 "Rofecoxib, a new cyclooxygenase 2 inhibitor, shows sustained efficacy, comparable with other nonsteroidal anti-inflammatory drugs: a 6-week and a 1-year trial in patients with osteoarthritis. Osteoarthritis Studies Group" @default.
- Q73293587 P2093 "A Samara" @default.
- Q73293587 P2093 "B Daniels" @default.
- Q73293587 P2093 "C Fisher" @default.
- Q73293587 P2093 "D van der Heijde" @default.
- Q73293587 P2093 "J Bolognese" @default.
- Q73293587 P2093 "K Saag" @default.
- Q73293587 P2093 "R Sperling" @default.
- Q73293587 P304 "1124-1134" @default.
- Q73293587 P31 Q13442814 @default.
- Q73293587 P356 "10.1001/ARCHFAMI.9.10.1124" @default.
- Q73293587 P433 "10" @default.
- Q73293587 P478 "9" @default.
- Q73293587 P50 Q73293584 @default.
- Q73293587 P577 "2000-11-01T00:00:00Z" @default.
- Q73293587 P698 "11115219" @default.
- Q73293587 P921 Q62736 @default.